✦ LIBER ✦

DNA Methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer

✍ Scribed by Steven A Belinsky; Joan H Schiller; Christine A Stidley

Book ID: 109381379
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 87 KB
Volume: 66
Category: Article
ISSN: 0029-6643
DOI: 10.1111/j.1753-4887.2008.00061.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Finding biomarkers for non-small cell lu

Finding biomarkers for non-small cell lung cancer diagnosis and prognosis

✍ Tian Xiao; Lei Bao; Hongbin Ji 📂 Article 📅 2012 🏛 SP Higher Education Press 🌐 English ⚖ 175 KB

Non-surgical therapy for patients with a

Non-surgical therapy for patients with advanced non-small cell lung cancer

✍ ML LIAO 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Non-surgical therapy for patients with a

Non-surgical therapy for patients with advanced non-small cell lung cancer

✍ Stephen J CLARKE; Michael J BOYER 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

Recent advances in etoposide therapy for

Recent advances in etoposide therapy for non-small cell lung cancer

✍ Philip Bonomi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Non-small cell lung cancer (NSCLC) continues to be a major health problem in the US. In 1990, approximately 120,000 new cases will be diagnosed, and the majority of these patients will have either unresectable disease or resected disease that has a relatively low chance of being cured. A variety of

Different histological types of non-smal

Different histological types of non-small cell lung cancer have distinct folate and DNA methylation levels

✍ MingJi Jin; Kazuyuki Kawakami; Yousuke Fukui; Sayaka Tsukioka; Makoto Oda; Go Wa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

The current status of targeted therapy f

The current status of targeted therapy for non-small cell lung cancer

✍ H. Francis; B. Solomon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB